'A bed in the middle of nowhere': parents' meanings of place of death for adults with cystic fibrosis by Lowton, Karen
1 
 
‘A bed in the middle of nowhere’: parents’ meanings of place of death for adults 
with cystic fibrosis 
 
Abstract 
As populations age and chronic conditions become more prevalent, an individual's ability to choose 
the location of their end-of-life care and death is increasingly considered important in the provision 
of good healthcare, with home implied as the ‘best’ place of death through UK government policy 
and specialist and voluntary palliative care services. However, considering meanings of place of end-
of-life care and death is complex for young adults with life-limiting conditions where the disease 
course is variable and uncertain, and aggressive and palliative treatments are administered both at 
home and in hospital often until death. Although ‘place’ is a pivotal element in healthcare practice, 
research and policy, there has been little attempt to understand the meaning and importance of place 
in understanding experiences of care at end of life. Through analysis of in-depth interviews and 
letters received from parents of 27 young adults in England, Scotland and Wales who died from 
cystic fibrosis from 1999 to 2002 aged 17–36 years, key factors that influence families' meanings of 
place at end of life are presented. Both home and hospital deaths are reported, with no deaths in 
hospices. Preferences for possible locations of death are generally limited early in the disease course 
by choice of aggressive treatment, particularly lung transplantation. Rate of health decline, 
organisation and delivery of services, and relationships with specialist and general healthcare staff 
strongly influence parents' experience of death at home or in hospital, although no physical location 
was regarded a ‘better’ place of death. Meanings of, and attachment to place are mediated for 
families through these factors, questioning the appropriateness of a ‘home is best’ policy for those 




The bulk of treatment and care for those with chronic illness in Western societies is increasingly 
taking place in the home, fuelled by social and economic pressures (Cartier, 2003 and Martin et al., 
2005) and the ability to move medical and assistive technologies into the home setting (Exley and 
Allen, 2007 and Poland et al., 2005). Advantages of the home environment for individuals include 
autonomy, control, security, privacy, and relaxation (e.g. Downing, 2008, Dyck et al., 2005 and 
Poland et al., 2005), features not regularly associated with a public hospital environment. The value 
of home care is influenced by interactions with family members giving care and being surrounded by 
comforts such as cherished artifacts, memories, and established routines (Exley and Allen, 2007 and 
Gott et al., 2004), although less idealistic home environments also exist, such as those in unsafe 
neighbourhoods (Downing, 2008), or lived in isolation. 
 
As populations age and chronic conditions become more prevalent, an individual's ability to choose 
the location of their end-of-life care and death is increasingly considered an important factor in the 
provision of good healthcare and promoted in UK government policy (Department of Health, 2006 
and Department of Health, 2008). This is often achieved through care pathways predicated on 
identifying an end-of-life stage, and encouraging professionals to initiate discussion of care 
preferences (Department of Health, 2008). However, a range of factors influences ability to choose 
place of death, including physical characteristics of disease, service availability (Grande, Addington-
Hall, & Todd, 1998), access to specialist equipment (Karlsen & Addington-Hall, 1998), and informal 
carer support (Gomes & Higginson, 2006). The notion in recent policy that home is the ‘best’ 
location for a ‘good’ death (Department of Health, 2006) is further advocated in specialist and 
voluntary palliative care services, primarily for those with cancer (e.g. Grande et al., 1998 and Marie 
Curie Cancer Care, 2004). Here the benefits of home care for those with chronic conditions are 
echoed through a home death suggested to allow individuals a greater sense of control over their 
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environment and maintenance of privacy and a sense of normality (Gott et al., 2004). However, an 
immediate stated preference for home-based care at end of life may become moderated following 
reflection and discussion, for example appreciation that better care quality may be found in a hospital 
setting (Seymour, Payne, Chapman, & Holloway, 2007); preferences being variously influenced by 
social, interpersonal and pragmatic considerations (Morris, 2005 cited in Seymour et al., 2007). 
 
Concepts of ‘place’ are complex and contested, being informed by disciplines including sociology 
and health geography. Broadly, place is an abstract concept of space ‘transformed and given cultural 
meaning by human activity’ (Cartier, 2003:2291). Although closely intertwined, three forms of place 
from which people give and take meaning can be observed: the physical or built environment that is 
developed over time; the social environment, in terms of how places are structured, organised and 
used; and the psychological environment, in terms of meanings of place across the lifecourse (Martin 
et al., 2005 and Peace et al., 2007). Places therefore bring people together, who subsequently become 
engaged with or estranged from their environment through bonding, associating meanings, and 
accumulated biographical experiences and events (Gieryn, 2000 and Peace et al., 2007). 
 
Although ‘place’ is a pivotal element in healthcare practice, research and policy, there has been little 
attempt to understand the meanings, significance and importance of aspects of place in understanding 
experiences of care (Poland et al., 2005) or the social and symbolic aspects of places such as home 
and hospital (Martin et al., 2005). In the context of end-of-life care, greater investigation is needed of 
whether home really is the ‘best’ place of care, with reasons behind stated preferences requiring a 
much fuller understanding (Thomas, Morris, & Clark, 2004). 
 
Cystic fibrosis (CF) is a multi-systemic condition, particularly affecting the lungs, whereby thick, 
sticky secretions lead to a cycle of lung infection and inflammation, reducing lung capacity over the 
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lifespan (Davies, Alton, & Bush, 2007). Three decades ago the majority of those affected did not 
survive childhood, yet now fuller understanding of the disease and development of more effective 
and aggressive treatments has dramatically improved life expectancy, such that median survival age 
of over 50 years is predicted for those born with CF in 2000 (Dodge, Lewis, Stanton, & Wilsher, 
2007). 
 
Current treatment and care for CF is complex, with preventative, restorative and palliative treatments 
administered in tandem throughout the lifecourse (Robinson, 2000). Routine treatments such as 
physiotherapy and intravenous antibiotics are carried out in the home, where young adults are most 
often assisted in their care by family members (Lowton, 2002 and McGuffie et al., 2008). As young 
people age and health declines, individuals become more dependent on aggressive or invasive 
procedures for survival. For example, non-invasive ventilation is used to manage acute respiratory 
failure in those awaiting lung transplantation (Madden et al., 2002), currently the last treatment 
option available. The vast majority of the CF population dies from respiratory failure, although the 
uncertain and unpredictable disease course makes predicting the precise time and nature of death, 
and therefore planning palliative care, difficult (Robinson, 2000). 
 
Although thoughts of a likely early death will have a significant psychosocial impact on families 
(Kurland & Orenstein, 2001), only a small body of research has been conducted on where those with 
CF die, as the community's focus understandably lies on improving survival (Robinson, 2000). A 
hospital record review of 44 North American patients aged 6–46 who died between 1984 and 1993 
found that only one patient died at home under hospice care, the remainder dying in hospital, with 
43/44 families present at death (Robinson, Ravilly, Berde, & Wohl, 1997). Similarly, a survey of 17 
CF centres in the UK and Ireland over an eight year period found that only 4% of 378 deaths had 
occurred at home (Cottrell, 1991). More recent reviews of hospital records indicate that over two 
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thirds of patients with CF die in hospital (Dellon et al., 2007 and Mitchell et al., 2000), reflecting 
both the proportion of patients receiving aggressive treatment at time of death and professionals' 
uncertainty over identifying the ‘final illness’ (Robinson, 2000). 
 
Use of mechanical ventilation and lung transplantation, first attempted for those with CF in the late 
1980s, has led to a higher proportion of hospital deaths occurring within the intensive care unit 
(ITU), with those waiting for, or having received, lung transplant more likely to be intubated at or 
shortly before time of death and likely to die quickly after ventilatory support is withdrawn (Dellon 
et al., 2007 and Ford and Flume, 2007). Although clinical outcomes of patients with CF admitted to 
ITU have much improved over the last two decades, under half of those currently admitted survive to 
hospital discharge (Vedam, Moriarty, Torzillo, McWilliam, & Bye, 2004). Furthermore, around half 
those who opt for transplant die while waiting for donor organs; half of those who do undergo 
transplant will not survive five years (Ford & Flume, 2007). 
 
Aggressive interventions being delivered in hospital environments until the point of death (Dellon et 
al., 2007 and Mitchell et al., 2000) allow little clear transition from therapeutic care to a traditional 
model of palliative care. Few unambiguous signals can therefore be given to families that end-stage 
CF has been reached (Robinson, 2000) and that place of death should be considered. Furthermore, it 
is not known whether young people are at increased risk of receiving unwanted treatment and feeling 
more unsatisfied with end-of-life care than those dying at home (Dellon et al., 2007). 
 
Other than reliance on mechanical ventilation, suggested reasons for the minority of home deaths in 
this population include specialist centre staff having little experience of patients dying at home, thus 
little knowledge of community support available, and that patients with CF, through their long 
involvement with the centre, might feel more secure amongst a familiar healthcare team (Robinson, 
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2000). Although the shift towards routine CF care performed in the home mirrors the emphasis on 
home care for those with other chronic conditions, whether those with CF die in hospital locations 
due to preference or lack of alternative options (Dellon et al., 2007), and how families experience 
and interpret place of end-of-life care and death, is not known. The aim of this paper is to present 
factors that influence and provide meanings of place of end-of-life care and death in terms of 
engagement with, and estrangement from, the built, social and psychological environment for 
bereaved parents of adults with CF. 
 
Methods  
In order to comply with the UK Data Protection Act 1998, letters about the project were sent 
nationally in September 2003 by the CF Trust to 275 families that it was aware had experienced the 
loss of a relative in the years 1999–2002. This timeframe was chosen to minimise the risk of 
contacting relatively newly bereaved respondents, whilst attempting to maintain currency of their 
experiences. Those interested were asked to give their contact details to the author, who sent them 
further information in the form of an information sheet and topic guide detailing the areas of enquiry. 
The topic guide, written as a series of questions under broad subject headings (Table 1), alerted 
respondents that the focus was firmly on death and dying, allowed them time to collect their thoughts 
before participating, and helped to ensure that verbal consent taken at the beginning of the interview 
was as fully informed as possible. Written consent to use the audio recording was obtained at the end 
of interviews. 
 
TABLE ONE ABOUT HERE 
 
Respondents were offered a choice of face-to-face interview, writing a letter or recording their 
experiences onto cassette, methods previously used to investigate the effects of illness on parents of 
7 
 
young people with cancer (Grinyer & Thomas, 2001). Those writing a letter or making a recording 
were asked to respond to the questions on the topic guide sent with the invitation letter. All 
respondents were assured that they did not have to answer questions they preferred not to, and that 
they were welcome to share information they thought relevant but had not been covered by the topic 
guide. All interviewees were told that they could stop the interview whenever they wished; although 
recording was stopped at points to allow participants time to mourn, all requested that they complete 
the interview. King's College London Research Ethics Committee granted ethical approval of the 
study. All participants were assured that their responses would be confidential and anonymised 
through use of pseudonyms. 
 
Due to the method of posting the initial letters, it is not known how many letters sent by the CF Trust 
reached their destination. Many parents sever links both with CF services and other families affected 
by CF after their child's death; others move house (perhaps signifying the meaning and value of 
‘home’) and some separate. Seventy-one people out of the 275 contacted requested further 
information. Two of these (both mothers) spoke at length to the author by telephone but did not want 
their stories included in the study. Both expressed dissatisfaction with their child's end-of-life care. 
Thirty-four individuals (32 of them parents) from 25 families located in Scotland, Wales and 
England participated during October 2003–March 2005, reporting 30 deaths of children from CF. No 
partners participated. Seven people wrote letters ranging from 1000 to 12,500 words; 26 people were 
interviewed either with a spouse or individually; and one sent a cassette (Table 2). 
 
TABLE TWO ABOUT HERE 
 
Due to the genetic basis of the disease, some families reported deaths of more than one child with 
CF. Three parents narrated the deaths of two children and one couple recounted the deaths of all 
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three children. Three of these children, aged 14 or under, died before 1994 and were not included in 
the analysis. Two families had another child living with the condition at the time of participation. 
 
Analysis  
All material was transcribed verbatim and checked against the original source (audio recording or 
letter) for accuracy. All data were imported into ATLAS-ti, the software package for qualitative 
analysis. Codes were assigned to words, phrases, paragraphs or sentences to assist with detection of 
themes and patterns (Miles & Huberman, 1994). Codes for place of death were assigned to home or 
locations within the hospital, and factors that appeared to influence positive and negative experiences 
of care were considered. During coding all respondents' transcripts were reread to ensure capture of 
how parents' reports of earlier experiences of care impinged on the meanings they attributed to the 
final place of care and death. Second order coding was used to identify recurrent themes and 
patterns, and to further understand reasons for negative cases. 
 
Parents' accounts of deaths from 1999 to 2003 are reported for 27 adults with CF aged 17–36 years. 
The median age of death for men was 26 years and 22 years for women. Six young people were 
reported to have died at home and 21 in hospital. Although variability of the disease makes 
classifying ‘unexpected’ deaths difficult, respondents' accounts ranged from sudden deaths to health 
decline over a prolonged period, with eight young people reported to have refused to consider lung 
transplantation, or to have taken too long to make their decision when possibility of the intervention 
was first raised. In considering parents' meanings of place of death, findings are organised by the 





The built environment  
Twenty-one hospital deaths were reported; locations included specialist CF or transplant centres, 
local and district general hospitals. Twenty young people died whilst admitted for an episode of 
acute illness and one whilst being assessed for transplant suitability. Six died in ITU, one in the 
infectious diseases unit (IDU, used to protect young people from infection), one on a CF unit, and the 
remainder on hospital wards. Parents reported hospitals' variable provisions for family members 
during young people's admissions, from put-up beds to separate accommodation, with parents 
tending to report staying only for critically ill offspring. Parents reported being present for all but 
three young people's deaths, two of whom died on a ward and one in IDU. These ‘absent’ parents 
reported engagement with hospital environments across the disease course, and good care for their 
offspring at a point that they had not anticipated as becoming their place of death. Two families' 
absence was due to needing to fulfill home responsibilities, coupled with a long distance to hospital 
prohibiting speedy return, whilst for the other, absence was due to the unexpected and extremely 
sudden nature of death: 
 
    I said [to Tom], “Do you want me to come up and stay [at the hospital]?”…And he said, “That'd 
be lovely, Mum.” So I made all the arrangements, this was on the Sunday…I phoned up on the 
Monday morning and said, “What sort of night has Tom had?” and they said, “Oh, all right.” Half an 
hour later, the phone went and it was Sister and she said, “Rita, you'll have to come, but don't hurry, 
he's gone.” [Tom's mother, interview, ward death] 
 
Through a long period of care enabling parents' familiarity with the hospital built environment and 
medical technologies housed within, a clear engagement with the built environment was reported by 
five out of six parents who experienced their child's death in ITU. Parents who reported a home death 
were similarly engaged. However, two out of 13 families reporting hospital ward deaths recounted 
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problems arising from their having little control over the layout of the built environment and limited 
opportunity to leave the bedside: 
 
    It was horrendous! Absolutely horrendous! Because there was her bed like that [indicates with 
hands], and at the end of the bed was a full-length mirror and a clock. And she was just watching – 
she was watching herself die, and looking at the time. And I can tell you the exact minute she could 
die. We all did. Because we knew. Because that clock was there… And I can just – it was horrible, 
because you're watching the clock. [Dawn's mother, interview, ward death] 
 
Despite being in a single room, a lack of privacy in the ward environment resulted from the 
arrangement of fixed items and parents' reported inability to move to a private space when 
attempting to talk to relatives about the dying young person: 
 
    I always thought if only they could have covered it [the payphone]. What a simple thing! Even if it 
wasn't really soundproofed, it would be a little bit of privacy for parents to sit and talk. Because also 
Edward was in room four, which was dead opposite [the payphone]. And very often a door would be 
open. And if I was trying to talk to [family members] about him or his condition, it's so difficult! I 
mean, how could I actually say to them, “He's so ill. Will you come?” [Edward's mother, interview, 
ward death] 
 
In thinking of whether a particular built environment was preferred as a place of death, both 
Andrew's mother, who recounted unsuccessful resuscitation attempts following Andrew's collapse at 
the specialist centre where he was being assessed for lung transplant, and the mother of Adam, who 
died unexpectedly at home using non-invasive ventilation whilst waiting for transplant, reported that 




    [Author]: Would you have rather Andrew had died at home? I mean, if he got to the point where – 
? 
 
    Mother: [sighs] No, I don't think I would, because I think then I would have been asking myself, 
“Now, would it have been different if he'd been in hospital?” [Andrew's mother, interview, CF unit 
death] 
 
However, although both sons had opted for a lung transplant ‘pathway’ where a range of aggressive 
treatments delivered both at home and in hospital are the norm, Adam's mother intimated that to be 
taken to hospital would have led to his receiving futile resuscitative treatment, which would only 
have prolonged his dying: 
 
    I was so lucky the CF nurse was there [on a routine visit at home]. Because if I'd come home and 
found Adam like that [semi-conscious] – because he might have been like that – and if he would 
have kept going, once I'd sort of screamed a bit, I suppose I would have called an ambulance, 
because I don't, I wouldn't really know what else to do. And he would have gone to hospital! Oh 
God! Can you imagine? [Adam's mother, interview, home death] 
 
In each participant's account, the built environment can be seen as a proxy for parents for the choice 
of treatment pathway, and the availability of care. ‘Place’ in this context determined for parents both 
availability of technological interventions and staff at end-of-life, mediated by the speed of 
offspring's health decline, the social organisation and delivery of care, and families' relationships 




The social environment 
Determining location of death through rate of health decline  
Evident throughout accounts was how the speed of health deterioration influenced treatment options 
available. Only one young person was reported to have undergone cardio-pulmonary resuscitation 
following collapse, which was unfortunately unsuccessful. This extremely rapid, unexpected health 
deterioration and sudden death occurred whilst Andrew was admitted for transplant assessment and 
aggressive care which attempted to improve both the quantity and quality of his life. In contrast, a 
relatively slow rate of health decline enabled other young people, their family, and a range of 
hospital and community services to plan for structured, supportive end-of-life care to be delivered at 
an agreed location, although this was not necessarily home. For example, Jude had reportedly 
refused transplant assessment and had parents experienced and competent in delivering CF care 
being supported by CF and community teams. However, he was reported to not want to leave the 
hospital to die at home; his engagement with the ward environment appeared at odds with what his 
parents had anticipated, and suggested the primacy of his safety and security within the ward, 
perhaps through engagement with familiar trusted staff, or through not wishing to be a burden on 
family members: 
 
    I said, “Well, we won't say anything to Jude about bringing him home until we find out whether 
or not we can get any sort of support.” So [the CF team] spent a couple of days – I think they liaised 
with the GP, and they'd said, “… the Macmillan nurses will provide a sitter two nights a week so 
obviously the pair of you [Jude's parents] can get some sleep. And your GP's prepared to do 
whatever.” I suppose see to the morphine and stuff like that, I'm not sure exactly what would have 
been involved. We were all quite au fait with the syringes and drawing up the drugs and all that, so it 
wasn't going to be a problem… When we knew that we could do it, I said to Jude, “Do you want to 
go home then?” And he said, “No, I think I'll stay in hospital, Mum,” because he said that the nurses 
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are more au fait with everything and, “I forgot to have my medication changed and it might be a bit 
difficult.” [Jude's mother, interview, ward death] 
 
In contrast, although Nathan had also decided against lung transplantation assessment and 
aggressive intervention, he and his family were able to initiate plans for an end-of-life care 
‘pathway’ that enabled him to die in the family home environment, which involved inputs from the 
CF nurse specialist, hospice and district nursing teams. Planning a home death could also occur at a 
relatively late stage in the transplant ‘pathway’. For example, following admission to the transplant 
centre for surgery, where donor lungs were found to be damaged and therefore unusable, one young 
woman had requested to be taken off the transplant list. Tamsin, living with her husband at her 
parents' home, was able to plan a home death after the CF team gave a clear signal that her care 
pathway had then changed from active to palliative, and discussed options with her family: 
 
    Basically, [the CF team] said, “Well, we know she hasn't got very long. It might only be a matter 
of days. And what she really wants is to be at home.” And we said, “Yes, that's fine.”…She came 
home, and [her husband] had compassionate leave from work, and we nursed her at home. [Tamsin's 
father, interview, home death] 
 
Evident in these accounts of health decline is the organisation and coordination of a range of 
services that are required to respond to a change in health status in both the hospital and home 
environments. In the following section, how social organisation of this care and interactions with 
staff influenced experiences of end-of-life care are considered. 
 
Organisation and delivery of care 
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The concept of opposing pathways of refusing transplant or opting for aggressive treatment is 
vital in understanding current organisation and delivery of end-of-life care for those with CF. 
Usually, these pathway choices imply an opportunity to discuss potential place of dying 
relatively early in the disease course. However, five young people, reported not to have 
wanted transplant assessment, had not expressed to their parents a wish to die at home. For 
three of these, parents subsequently perceived the hospital ward as a place of safety for them, 
due to the availability of familiar staff and palliative interventions. However, for the other two 
young people who had refused transplant assessment and had died on hospital wards, absence 
of supportive organised care led respondents to recount a bad end-of-life experience. For 
example, Kenny's mother had reported ward doctors' care of her other son with CF at end-of-
life as “absolutely marvelous”, but remained extremely distressed by her experience of 
Kenny's death: 
 
    By the time the nurse came in – who we didn't know – she said, “Oh, he's dead.” Well, I felt 
like swearing at her. And I said: “We know he's dead.” Well, she went! She went! And we 
were half getting him [back] on the bed, and one of the nurses just came in and took his 
injection, his needle out from his stomach, and we were trying to get him on his bed…No-one 
came in and oh, it was dreadful! It was just dreadful. Really, really dreadful. I would not let, I 
would not let – I mean I love animals, and I wouldn't let an animal die like that! [Kenny's 
mother, interview, ward death] 
 
Five families reported six young people to have died in the ITU whilst receiving aggressive 
treatment. All, having opted for transplantation, were using mechanical ventilation, which 
ultimately determined their place of death. Mark, awaiting assessment for transplantation, was 
using non-invasive ventilation; the remainder were intubated. Two of the five intubated died 
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whilst waiting for donor organs, and three had received a transplant. The suddenness of death 
following withdrawal of invasive ventilation for these five meant that it was inappropriate to 
consider another location of care once the outcome was considered terminal. 
 
Established and valued relationships with CF teams had been built through patients‘ and 
families’ long period of contact with them. Parents of the five intubated young people who 
died in ITU appeared engaged through shared decision-making about care, privacy, and a 
peaceful death. These deaths were reported to have been very sensitively managed by CF 
teams, who discussed care preferences with families and sensitively managed advanced 
technologies in an attempt to balance hope for those waiting for donor organs with 
acknowledgment that an end-stage had been reached: 
 
    I was advised on the Sunday morning to consider taking her off the life support as the 
infection was not responding to the huge amounts of antibiotics and the scarring on the lungs 
had caused the lungs to harden/stiffen. By Sunday afternoon her kidneys had failed and I was 
informed that if I did bring her round she may have suffered brain damage. I could not let her 
suffer ANYMORE; she deserved so much more than this. I decided to let her go peacefully in 
my arms, on our own. It was only an hour at the most from the time that all of the medications 
other than morphine and ventilation were stopped, that she passed away. [Diana's mother, 
letter, ITU death] 
 
However, one parent did not perceive such good care to have been delivered at end-of-life in 
ITU. This was not due to staff's poor care, but rather frustration over local hospital policy 
restricting the use of non-invasive ventilation to high dependency areas, although parents at 
other hospitals reported offspring using this technology in both ward and home environments. 
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Here, location of end-of-life care was intimately bound to local hospital policy and the 
dependency on advanced technology in supporting both living and dying: 
 
    Mark had reached the stage that, although he could converse, and was still bright, he could 
not breathe for more than a short while without a BiPAP [non-invasive ventilation] machine. 
[The hospital] have regulations forbidding use of BiPAP outside the Intensive Care and High 
Dependency units. These regulations are just local bureaucracy…He would have been happier 
to end his days with the Isolation team. We appreciate that the hospital takes steps to avoid 
being sued for inadequate care. However, over 24 h before he died, they wanted him to 
unblock the bed by returning him to isolation with no BiPAP. That would have been death 
within minutes, which we all objected to whilst there was the slightest chance of a transplant. 
Also, the death would have been painful struggling for the last breath without assistance. 
[Mark's father, letter, ITU death] 
 
A generally high standard of end-of-life care organised and delivered without the use of 
advanced technology was also apparent in more ‘low tech’ hospital deaths outside the ITU. 
Although Dean's parents had not been able to reach hospital in time, they reported being 
reassured by the presence of a familiar nurse: 
 
    Dean's Father: We met all of the nurses and we knew all the team. And [the nurse] even 
said, “I gave him a cuddle” you know. 
 
    Mother: By all accounts, he just, she sat at the side of him, and he wasn't laying down – he 
couldn't bear to lay down. And she said, “I put my arms around him.” And she said, “Come 
on, love, put your head on my shoulder.” And she said, “I realised that he was going. But I 
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couldn't leave him and go and get the phone and ring you.” And she pressed the [call] button 
to let the night nurse know that this was what was happening. [Dean's parents, interview, IDU 
death] 
 
Rarely, bad experiences of end-of-life care, predominantly experienced through ward-based 
deaths, were reported by parents and were attributed to a lack of relational continuity of care: 
satisfactory relationships with certain CF team members had not been established; key 
members of the CF team were not available for consultation; or unfamiliar staff were 
perceived to be untrained and uncaring. For one mother, nurses calling in specialist palliative 
care staff only at the very end of her daughter's life demonstrated an ill-timed coordination of 
services that did not allow for establishment of personal relationships: 
 
    I was really annoyed, because about two hours before she died, [the nurses] called me 
outside and said, “Look, we've got the palliative care nurse here,” – who I'd never, ever 
clapped eyes on before – “would you like her to come and sit with you?” And I think I 
snapped, “No, thank you! I'm quite alright!” Because I didn't want a stranger there. [Dawn's 
mother, interview, ward death] 
 
In summary, rate of health decline, organisation and delivery of care, and relationships with 
staff were key factors of the social environment that determined how an offspring's death was 
experienced by parents. These were mediated by, but not dependent on, physical location. 
Briefly, we consider to what extent parents reported taking meaning from place of death. 
 
The psychological environment 
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Parents believed that their offspring perceived locations in the hospital environment to 
be both places of threat and safety throughout their lifecourse, through admissions 
signifying an increased risk of death, yet offering ‘rescue’ therapy, familiarity and 
comfort at points of acute illness. Ambiguity surrounding the meaning of hospital 
admission was compounded by the array of home-based technologies that was available 
to young people, which they were reported to use in attempts to delay hospital 
admission. This ongoing ambiguity may have contributed to young people's reported 
inability to choose and express clearly a preferred place of death. 
 
Through their years of hospital appointments and admissions the vast majority of parents 
reported their children knowing other young people who had died from CF. Symbolic 
meaning was taken from the physical environment through memories of these others' 
deaths, which some parents reported to influence their child's albeit restricted choice of 
place of death, especially within a ward environment experiencing a high number of CF 
admissions: 
 
    The doctor said to me, “He should be in a room on his own,” because there's like a 
ward full of people there and Kenny was a spectacle really…I said that he won't go in 
the room that they've offered him, because his friend died in there a couple of months 
ago, and he won't, he just feels awkward, because he doesn't want to go in that room. 
[Kenny's mother, interview, ward death] 
 
However, focusing on place of death per se appeared to be of far less importance to 
parents than focusing on factors that influenced positively experiences of care at end-of-
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life. Indeed, place as a physical environment may be irrelevant to some parents and their 
dying relative: 
 
    Did Mark die where we would have wished? We would have preferred him not to die. 
However, we held his hand for the last 48 h and the location is of minor importance. 
[Mark's father, letter, ITU death] 
 
It appears from parents' accounts that it is the availability of advanced technology to 
support the choice of aggressive care or refusal of transplant, and familiar, trusted staff 
available to young people and their family at the time of death that are of paramount 
importance to families in determining and giving meaning to place of death. Nadia's 
mother summed up this belief in the context of her daughter's death which she reported 
with great upset; familiar CF team members had been absent and hospital nurses were 
reported as being uncaring and uncommunicative both before and after Nadia's death: 
 
    But it doesn't matter if you're in a bed in the middle of nowhere; if you're getting love, 
attention and care, it doesn't matter where you die, really, as long as the way you die is 
done with dignity. [Nadia's mother, interview, ward death] 
 
Discussion 
Considering meanings of the place of end-of-life care and death of young adults with a life-limiting 
condition is complex where the disease course is variable and uncertain, and aggressive and 
palliative treatments are often administered in tandem until death. The rapid health decline of many 
young people occurs against a background of significant improvement in this population's survival 
age, fuelling tensions between attempts to extend lifespan through use of advanced technology and 
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enabling young adults to die within a more traditional palliative care model. Within the physical 
boundaries set for the use of advanced technology such as mechanical ventilation, social, policy and 
symbolic contexts mediated parents' engagement with, or estrangement from, place, both at home 
and within hospital environments. In each location, family involvement in treatment decision-making 
with familiar and trusted staff was pivotal in parents' evaluation of end-of-life care for their children, 
although no physical location appeared to be the ‘best’ place of care or death for this population. 
 
Retrospective accounts from parents affected by the death of at least one child with CF have been 
presented. Although this small group is perhaps not representative, a wide range of final cause and 
location of death were reported from families who in total had accessed over 70 British healthcare 
services providing a wide range of CF-related treatment across their children's lifespan, with reported 
location and age at death similar to other recent studies (Dellon et al., 2007 and Ford and Flume, 
2007). All young people had at least one parent caring for them within a supportive social 
environment, with most parents reporting periods of engagement and estrangement with care over 
the young person's lifetime. Only parents' views are represented here; it is likely that young people 
and CF team members may express different opinions of care required and provided. 
 
Problems with using retrospective data include recall and subsequent events influencing perception 
of past events, such as the resolution of a complaint about hospital care. However, issues raised by 
parents concerning other children currently living with the disease were similar to those discussed for 
the deceased child. For example, difficulties surrounding advanced treatment decision-making due to 
uncertainty of the disease process suggest that although national policy now focuses more on end-of-
life care for those with non-malignant disease (Department of Health, 2008), this will take time to 
impact on ‘new’ ageing populations with life-limiting conditions where striving for improvement in 




The narrative accounts gained though respondents' letters have weaknesses; not all accounts 
suggested the choices offered to young people or their parents, offered reasons for decisions made by 
individuals, or explicitly expressed a preference for place of death or end-of-life care. However, this 
approach to data collection put minimal pressure to participate on families, whose experiences at 
end-of-life are usually lost to health services, policy makers and researchers. It also allowed people 
to write their story in their own time and pace and perhaps upheld families' desire not to meet with a 
stranger (Grinyer, 2002). It is likely therefore that concepts generated here serve to illuminate some 
of the complexities of providing end-of life care to young people who still do not survive mid-life 
(Dodge et al., 2007). 
 
It has been suggested that ‘place’ is a proxy measure of the quality of end-of-life care (Exley and 
Allen, 2007 and Gott et al., 2004); the physical location being of less importance than the social and 
emotional relationships housed within (Exley & Allen, 2007). Here for example, although ITU 
cannot emulate the physical characteristics of ‘home’ in terms of furnishings and artifacts, it has been 
demonstrated that a ‘good’ death in this high-tech environment is achievable, based on families' 
relationships with familiar supportive and trusted staff, and their felt inclusion in decision-making. 
Conversely, despite the comfort and privacy that single rooms in ward environments might offer, it is 
the general ward environment that appears less likely to offer a ‘good’ death, through staff reported 
to be unfamiliar with both the young person and the specialist care required. 
 
This study demonstrates that it is the use of more advanced technologies at end-of-life, housed in a 
range of locations within acute hospital environments that is an additional important proxy measure 
of the quality of end-of-life care for this population. Here, location of death was often limited by 
young people's rate of health decline and their choice of aggressive treatment. Notions of aggressive 
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care and end-of-life care are therefore intertwined for those affected by CF, with place of death being 
influenced by the two care pathways. Advanced technologies usually determined place of end-of-life 
care and death within the ITU or high dependency environment, thus limiting families' preference 
and capacity to provide care at home. Policy for a ‘good’ death must therefore take into account the 
use of advanced and evolving technological interventions within each space and the potential for its 
restriction or portability to alternative settings. 
 
However, home and hospital ward environments continue to become more fluid for these ‘new’ 
ageing populations through the movement of more ‘simple’ routine technologies such as intravenous 
drug equipment into the home setting (Poland et al., 2005). Through routine home care provided 
throughout the lifespan, home space for this population may already be considered as a quasi-clinical 
context. Furthermore, frequent hospital admission and regular invasive therapy can ensure long and 
trusted relationships with professionals within the hospital environment, which then has the potential 
to become a ‘home-from-home’ for those dependent on medical interventions throughout life. 
‘Home’ cannot therefore be the sole policy focus for defining the ‘best’ place of death for this highly 
medicalised, technology-dependent population, used to receiving treatment and care across a variety 
of familiar built environments. If professionals understand and respond to these factors that families 
deem important, then a ‘good’ death can occur in places outside the home (Grinyer & Thomas, 
2004). 
 
An end-of-life care strategy must therefore focus both on specific locations within the built 
environment of ‘acute hospital’ care (Department of Health, 2008) and home, and the technological, 
social, and psychological processes found therein. Attempts to increase the proportion of home 
deaths for ‘new’ ageing populations such as those with CF are likely to be misguided if these 
elements are not addressed. As more people with life-threatening conditions live lives dependent on 
23 
 





Cartier, C. (2003). From home to hospital and back again: economic restructuring, end of life, and 
the gendered problems of place-switching health services. Social Science & Medicine, 56, 2289-2301 
Cottrell, J. (1991). The role of the cystic fibrosis nurse specialist in terminal care and bereavement. 
In David, T.J. (ed) Role of the cystic fibrosis nurse specialist: Proceedings of a meeting held in 
London, 21 November 1991. Oxon, Medicine Group (Education) Ltd. 
Davies, J.C., Alton, E.W.F.W., & Bush A. (2007) Cystic Fibrosis. British Medical Journal, 335, 
1255-1259. 
Dellon, E.P., Leigh, M.W., Yankaskas, J.R., & Noah, T.L. (2007). Effects of lung transplantation on 
inpatient end of life care in cystic fibrosis. Journal of Cystic Fibrosis, 6 (6), 396-402. 
Department of Health (2004) 
Department of Health (2006). Our Health, Our Care, Our Say: A new direction for community 
services. London, HMSO. 
Department of Health (2008). End of Life Care Strategy: Promoting high quality care for all adults 
at the end of life. London, HMSO. 
Dodge, J.A., Lewis, P.A., Stanton, M., & Wilsher, J. (2007) Cystic fibrosis mortality and survival in 
the UK: 1947-2003. European Respiratory Journal, 29 (3), 522-526. 
Downing, M.J. Jnr. (2008) The role of home in HIV/AIDS: A visual approach to understanding 
human-environment interations in the context of long-term illness. Health & Place, 14, 313-322. 
24 
 
Dyck, I., Kontos, P., Angus, J., & McKeever, P. (2005). The home as a site for long-term care: 
meanings and management of bodies and spaces. Health & Place, 11, 173-185. 
Exley, C., & Allen, D. (2007). A critical examination of home care: end of life care as an illustrative 
case. Social Science & Medicine, 2317-2327. 
Fogarty, A., Hubbard, R., & Britton, J. (2000). International comparison of median age at death from 
cystic fibrosis. Chest, 117, 1656-1660. 
Ford, D & Flume, P.A. (2007). Impact of lung transplantation on site of death in cystic fibrosis. 
Journal of Cystic Fibrosis, 6, 391-395. 
Gieryn, T.F. (2000). A space for place in sociology. Annual Review of Sociology, 26, 463-496. 
Gomes, B, Higginson, I.J. (2006) Factors influencing death at home in terminally ill patients with 
cancer: systematic review. British Medical Journal,332, 515-521. 
Gott, M., Seymour, J., Bellamy, G., Clark, D., Ahmedzai, S. (2004). Older people’s views about 
home as a place of care at the end of life. Palliative Medicine, 18, 460-467. 
Grande, G.E., Addington-Hall, J.M., & Todd, C.J. (1998). Place of death and access to home care 
services: Are certain patient groups at a disadvantage? Social Science & Medicine, 47 (5), 565-579. 
Grinyer, A. (2002). Cancer in Young Adults: Through Parent’s Eyes. Open University Press, 
Buckingham. 
Grinyer, A., & Thomas, C. (2001) Young adults with cancer: the effect of the illness on parents and 
families. International Journal of Palliative Nursing, 2001, 7 (4), 162-170. 
Grinyer, A., & Thomas, C. (2004). The importance of place of death in young adults with terminal 
cancer. Mortality, 9 (2), 114-131. 
Karlsen, S., & Addington-Hall, J. (1998). How do cancer patients who die at home differ from those 
who die elsewhere? Palliative Medicine, 12, 279-286. 
25 
 
Kurland, G., & Orenstein D.M. (2001). Lung transplantation and cystic fibrosis: the psychosocial 
toll. Pediatrics, 107 (6), 1419-1421. 
Lowton, K. (2002) Parents and partners: the role of lay carers in the treatment and care of adults with 
cystic fibrosis. Journal of Advanced Nursing, 39 (2), 1-8.  
Madden, B.P., Kariyawasam, H., Siddiqi, A.J., Machin, A., Pryor, J.A., & Hodson, M.E. (2002). 
Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure. European 
Respiratory Journal, 19 (2), 310-313. 
Marie Curie Cancer Care. Supporting the Choice to Die at Home campaign 
http://campaign.mariecurie.org.uk/ accessed 26.07.2008 
Martin, G.P., Nancarrow, S.A., Parker, H., Phelps, K., & Regen, E.L. (2005). Place, policy and 
practitioners: On rehabilitation, independence and the therapeutic landscape in the changing 
geography of care provision to older people in the UK. Social Science & Medicine, 61 (9), 1893-
1904 
McGuffie, K., Sellers, D.E., Sawicki, G.S., & Robinson, W.M. (2008). Self-reported involvement of 
family members in the care of adults with CF. Journal of Cystic Fibrosis, 7 (2), 95-101. 
Miles, M.B., & Huberman, A.M. (1994). Qualitative data analysis. London, Sage. 
Mitchell, I., Nakielna, E., Tullis, E., & Adair, C. (2000). Cystic Fibrosis: End-stage care in Canada. 
Chest, 118, 80-84. 
Morris (2005) cited in Seymour, J., Payne, S., Chapman, A., Holloway, M. (2007). Hospice or 
home? Expectations of end-of-life care among white and Chinese older people in the UK. Sociology 
of Health and Illness, 29 (6), 872-890. 
Patterson,M.E., & Williams, D.R. (2005) Maintaining research traditions on place: diversity of 
thought and scientific progress. Journal of Environmental Psychology, 25, 361-380. 
26 
 
Peace, S., Wahl, H-W., Mollenkopf, H., & Oswald, F. (2007). Environment and Ageing, In Bond, J., 
Peace, S., Dittmann-Kohli, F., & Westerhof, G. (Eds) Ageing in Society (3rd Edition), Sage, London 
Poland, B., Lehoux, P., Holmes, D., & Andrews, G. (2005) How place matters: unpacking 
technology and power in health and social care. Health and Social Care in the Community, 13 (2), 
170-180. 
Robinson, W.M. (2000). Palliative care in cystic fibrosis. Journal of Palliative Medicine, 3 (2), 187-
192. 
Robinson, W.M., Ravilly, S.R., Berde, C., & Wohl, M.E. (1997). End-of-life care in cystic fibrosis. 
Pediatrics, 100 (2), 205-209. 
Robinson, W.M., Ravilly, S.R., Berde, C., & Wohl, M.E. (1998). Terminal Care in Cystic Fibrosis: 
Hospital versus home? In Reply. Pediatrics, 102 (2 part 1), 436-437. 
Seymour, J., Payne, S., Chapman, A., Holloway, M. (2007). Hospice or home? Expectations of end-
of-life care among white and Chinese older people in the UK. Sociology of Health and Illness, 29 
(6), 872-890. 
Small, N., & Rhodes, P. (2000). Too ill to talk? User involvement and palliative care. Routledge, 
London. 
Tang, S.T. (2003). When death is imminent, where terminally ill cancer patients prefer to die and 
why. Cancer Nursing, 26, 245-251. 
Timmermans, S. (1998). Resuscitation technology in the emergency department: towards a dignified 
death. Sociology of Health & Illness, 20 (2), 144-167. 
Thomas, C., Morris, S.M., & Clark, D. (2004). Place of death: preferences among cancer patients and 
their carers. Social Science & Medicine, 58, 2431-2444. 
27 
 
Thomas, S.R. (2003). The pulmonary physician in critical care. Illustrative case 1: cystic fibrosis. 
Thorax, 58 (4), 357-360. 
Vedam , H., Moriarty, C., Torzillo , P.J., McWilliam D., & Bye, P.T.P. (2004). Improved outcomes 




Table One: Abridged topic guide showing broad subject headings 
Events leading up to relative’s death 
Discussions between young person, staff and family about dying and death  
Consideration of organ transplantation 
Place of care at end of life 
Place of death  





Table Two. Participants recounting end-of-life care and death of a young adult with cystic fibrosis 
 
Name Age at death Place of death Respondents replying by letter (L), 
interview (I), or cassette (C) 
 
Diana 17 Hospital (ITU) Mother (L) 
Nadia 19 Hospital ward Mother (IV) 
Tamsin 20 Home Mother & Father (joint IV) 
Jude 20 Hospital ward Mother (IV) 
Clarissa 20 Hospital (ITU) Mother & Father (joint IV) 
Tamara 21 Home Mother (IV) 
Dawn 21 Hospital ward Mother (IV) 
Andrew 22 Hospital (CF unit) Mother (IV) 
Samuel 22 Hospital (ITU) Mother (L) 
Adam 22  Home Mother (IV) 
Edward 22 Hospital ward Mother (IV) 
Fergus 23 Hospital ward Mother & Father (joint IV) 
Dean 24 Hospital (IDU) Mother & Father (joint IV) 
Glenn 28 Home Mother (L) 
Lewis 30  Hospital ward Mother (IV); Sister (L) 
Julia 31 Home Mother (IV) 
Nathan 31 Home Mother & Father (joint IV) 
Sid 33 Hospital ward Mother (L); Father (L) 
Mark 33 Hospital (ITU) Father (L) 
Damien 36 Hospital ward Mother (IV); Sister (IV) 
Tom 36 Hospital ward Mother (IV) 
 
Siblings: 






















Hospital (transplant ward) 
 
 







19 Hospital (ITU) Mother (IV) 




24 Hospital ward Mother (IV) 
 32 Hospital ward 
 
 
